Non-alcoholic and alcoholic Fatty Liver Disease - two Diseases of Affluence associated with the Metabolic Syndrome and Type 2 Diabetes: the FIN-D2D Survey
Open Access
- 9 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Public Health
- Vol. 10 (1), 237
- https://doi.org/10.1186/1471-2458-10-237
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions are associated with MetS and abnormal glucose tolerance. Methods: The cohort included 2766 Finnish subjects (45-74 years) from the population-based FIN-D2D survey. Features of insulin resistance, components of the MetS, glucose tolerance status by oral glucose tolerance test, serum liver enzyme concentrations, and daily alcohol consumption were assessed. Results: Subjects with NAFLD and AFLD were equally obese and had similar fasting and insulin concentrations. The prevalences of NAFLD and AFLD were 21% (95% CI: 19%-22%) and 7% (95% CI: 6%-8%). The MetS was slightly more prevalent in AFLD (73%) than in NAFLD (70%, p = 0.028), and type 2 diabetes was similarly prevalent in NAFLD and AFLD (24-25%). The MetS and type 2 diabetes were more prevalent in subjects with NAFLD or AFLD compared to subjects with normal LFTs (53% and 14%, p < 0.0001 for both). Discussion and conclusion: In Finnish middle-aged population, the prevalence of NAFLD is 3-fold higher than that of AFLD. The prevalences of MetS and type 2 diabetes are, however, significantly increased in both NAFLD and AFLD compared to subjects with normal LFTs. Subjects with AFLD are thus similarly metabolically unhealthy as subjects with NAFLD.This publication has 30 references indexed in Scilit:
- High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish populationBMC Public Health, 2008
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLDHepatology, 2007
- Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver studyHepatology, 2005
- Elevated Serum GGT Concentrations Predict Reduced Insulin Sensitivity and Increased Intrahepatic LipidsHormone and Metabolic Research, 2005
- Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical courseBest Practice & Research Clinical Gastroenterology, 2004
- Association of Nonalcoholic Fatty Liver Disease With Insulin ResistanceJournal of Clinical Gastroenterology, 2003
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severityGastroenterology, 1999
- Biochemical markers of alcohol abuseQJM: An International Journal of Medicine, 1996
- The world health organization monica project (monitoring trends and determinants in cardiovascular disease): A major international collaborationJournal of Clinical Epidemiology, 1988
- Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations: Results from an intervention study in health subjectsAtherosclerosis, 1986